Blonder Tongue Laboratories Inc
BDR was delisted on the 24th of June, 2022.
9 hedge funds and large institutions have $364K invested in Blonder Tongue Laboratories Inc in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
1.15% more ownership
Funds ownership: 3.66% → 4.81% (+1.1%)
28% less capital invested
Capital invested by funds: $505K → $364K (-$141K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$132K |
| 2 |
VF
Virtu Financial
New York
|
+$23.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.01K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.46K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
BDR Hedge Fund Activity: Q4 2021 in Review
9 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q4 2021, worth a combined $364K — down 28% from $505K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BDR positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $132K.
- 9 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q4 2021, up from 8 in Q3 2021.
- Funds reported $364K of Blonder Tongue Laboratories Inc stock for Q4 2021, down 28% quarter-over-quarter.
- 2 funds opened new Blonder Tongue Laboratories Inc positions in Q4 2021 and 1 closed out, a net change of +1 holder.
- The largest Blonder Tongue Laboratories Inc buyer in Q4 2021 was Renaissance Technologies, an estimated $132K added.
Based on aggregated 13F filings for Q4 2021.